These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11018602)

  • 1. A positive caver map response poorly predicts recovery of potency after radical prostatectomy.
    Kim HL; Stoffel DS; Mhoon DA; Brendler CB
    Urology; 2000 Oct; 56(4):561-4. PubMed ID: 11018602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the CaverMap device help preserve potency?
    Kim HL; Mhoon DA; Brendler CB
    Curr Urol Rep; 2001 Jun; 2(3):214-7. PubMed ID: 12084267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erectile function after nerve-sparing radical prostatectomy. Nocturnal early erection as a parameter of postoperative organic erectile integrity].
    Bannowsky A; Schulze H; van der Horst C; Stübinger JH; Portillo FJ; Jünemann KP
    Urologe A; 2005 May; 44(5):521-6. PubMed ID: 15726311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a nerve-sparing technique or potency affect continence after open radical retropubic prostatectomy?
    Marien TP; Lepor H
    BJU Int; 2008 Dec; 102(11):1581-4. PubMed ID: 18808410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons.
    Walsh PC; Marschke P; Catalona WJ; Lepor H; Martin S; Myers RP; Steiner MS
    Urology; 2001 Mar; 57(3):491-4. PubMed ID: 11248626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacting factors for recovery of erectile function within 1 year following robotic-assisted laparoscopic radical prostatectomy.
    Ko WJ; Truesdale MD; Hruby GW; Landman J; Badani KK
    J Sex Med; 2011 Jun; 8(6):1805-12. PubMed ID: 21426493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
    Trinchieri A; Nicola M; Masini F; Mangiarotti B
    Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Briganti A; Fabbri F; Salonia A; Gallina A; Chun FK; Dehò F; Zanni G; Suardi N; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2007 Sep; 52(3):702-7. PubMed ID: 17418936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques.
    Menon M; Kaul S; Bhandari A; Shrivastava A; Tewari A; Hemal A
    J Urol; 2005 Dec; 174(6):2291-6, discussion 2296. PubMed ID: 16280816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative nerve stimulation predicts postoperative potency.
    Chang SS; Peterson M; Smith JA
    Urology; 2001 Oct; 58(4):594-7. PubMed ID: 11597546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study.
    Chang DW; Wood CG; Kroll SS; Youssef AA; Babaian RJ
    Plast Reconstr Surg; 2003 Mar; 111(3):1174-81. PubMed ID: 12621188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy.
    Zagaja GP; Mhoon DA; Aikens JE; Brendler CB
    Urology; 2000 Oct; 56(4):631-4. PubMed ID: 11018620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of unilateral nerve sparing in radical perineal prostatectomy.
    Brehmer B; Kirschner-Hermanns R; Donner A; Reineke T; Knüchel-Clarke R; Jakse G
    Urol Int; 2005; 74(4):308-14. PubMed ID: 15897694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
    Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
    BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurostimulation during radical prostatectomy: improving nerve-sparing techniques.
    Klotz L
    Semin Urol Oncol; 2000 Feb; 18(1):46-50. PubMed ID: 10719931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.
    Cathala N; Mombet A; Sanchez-Salas R; Rozet F; Barret E; Giuliano F; Galiano M; Prapotnich D; Kazzazi A; Djavan B; Jaffe J; Cathelineau X; Vallancien G
    Can J Urol; 2012 Aug; 19(4):6328-35. PubMed ID: 22892254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy.
    Klotz L; Heaton J; Jewett M; Chin J; Fleshner N; Goldenberg L; Gleave M
    J Urol; 2000 Nov; 164(5):1573-8. PubMed ID: 11025707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve sparing radical prostatectomy: a different view.
    Geary ES; Dendinger TE; Freiha FS; Stamey TA
    J Urol; 1995 Jul; 154(1):145-9. PubMed ID: 7776409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation.
    Rabbani F; Patel M; Cozzi P; Mulhall JP; Scardino PT
    BJU Int; 2009 Nov; 104(9):1252-7. PubMed ID: 19338540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.
    Davis JW; Chang DW; Chevray P; Wang R; Shen Y; Wen S; Pettaway CA; Pisters LL; Swanson DA; Madsen LT; Huber N; Troncoso P; Babaian RJ; Wood CG
    Eur Urol; 2009 May; 55(5):1135-43. PubMed ID: 18783876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.